RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice

por Richter, Antje M., Woods, Michelle L., Küster, Miriam M., Walesch, Sara K., Braun, Thomas, Boettger, Thomas, Dammann, Reinhard H.
Publicado 2020

RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer

por Richter, Antje M., Küster, Miriam M., Woods, Michelle L., Walesch, Sara K., Gökyildirim, Mira Y., Krueger, Marcus, Dammann, Reinhard H.
Publicado 2019

Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis

por Küster, Miriam M., Schneider, Marc A., Richter, Antje M., Richtmann, Sarah, Winter, Hauke, Kriegsmann, Mark, Pullamsetti, Soni S., Stiewe, Thorsten, Savai, Rajkumar, Muley, Thomas, Dammann, Reinhard H.
Publicado 2020